chemXplore
Product Pricing About Us
Sign in

Veritas In Silico Inc.

Japanveritasinsilico.com/en

Japanese biotechnology company specializing in AI-driven discovery of mRNA-targeted small molecule and nucleic acid drugs using its aibVIS platform. Engaged in joint research and patent filings with pharmaceutical partners for lncRNA-targeting therapies. Listed on Tokyo Stock Exchange Growth Market.

Also known as VIS.

Projects Veritas In Silico is involved in

None yet. When a new project in the record names Veritas In Silico as owner, partner or investor, it shows here.

Active projects close to Veritas In Silico

Country Japan 17 active of 20 tracked →

Veritas In Silico in chemical industry news

3 August 2026
Mitsubishi Gas Chemical and Veritas In Silico file patent for nucleic acid drug targeting lncRNA H19

Patent application covers a nucleic acid therapeutic against lncRNA H19 developed with an AI-driven discovery platform; commercialization planned using dedicated CRDMO capacity.